Bowman and Brooke Logo


While our firm is best known for defending automobile manufacturers, our lawyers counsel an array of Global 500 clients in high-stakes, national litigation in a range of industries.

Medical Device and Pharmaceutical

Stethoscope on a clipboard with medicine.

Bowman and Brooke's Medical Device and Pharmaceutical Litigation practice includes nearly two dozen experienced trial lawyers serving as national coordinating counsel; lead trial counsel, including at bellwethers; regional; and local counsel in a wide range of cases across the country, including some of today's most high-profile mass tort litigation. With a passion and drive for mastering complex medical, scientific, epidemiological, engineering and regulatory issues, Bowman and Brooke's lawyers deliver legal representation that is innovative and cost-conscious.

Our experience includes developing a formidable defense strategy aligned with your business objectives; serving as national coordinating counsel to implement a unified plan with the bandwidth to deploy a team of lawyers working up multiple cases at once; preparing discovery protocols and conducting large-scale document productions; preparing company witnesses for depositions and trial testimony; assessing litigation risks and the regulatory impact of litigation; ensuring a cutting-edge and consistent legal and appellate strategy; and, of course, trying cases before juries.

  • Oct 04, 2016
    October 14, 2016, CA
    Firm Chair Paul Cereghini commented in Law360 following a class certification denial involving Breg, Inc.'s cold therapy devices. In Stacey Lucas et al. v. Breg Inc. et al., plaintiffs sought a nationwide class certification alleging that Breg, Inc. provided false and misleading instructions regarding the use of its Polar Care 500 device. 
  • Apr 21, 2016
    Orange County, CA
    During a trial in the Superior Court of California, County of Orange, a judge granted a motion of non-suit in favor of Breg, Inc. in a case involving a Breg Pain Care 3000 pain pump. William Stovall v. Breg, Inc., Superior Court of California, for the County of Orange – Civil Complex Center, Case No. 37-2011-00059728, Judge William Claster presiding.
  • Mar 15, 2015
    In McKenna v. Breg, Inc., No. G048732, 2015 WL 917827 (Cal. Ct. App. 2015), a California appellate court upheld a jury verdict for device maker Breg, Inc. in February of 2013, after a three and a half week trial in the Superior Court for the State of California for the first bellwether case in the California infusion pump JCCP to go to trial, a jury returned a complete defense verdict in favor of Breg, Inc. Plaintiffs alleged that Breg was negligent and strictly liable for providing inadequate warnings with its Pain Care 3000 infusion pump.
  • Feb 06, 2013

    Breg, Inc. received a decisive win on February 6, 2013 in the first bellwether case in the California infusion pump JCCP to go to trial.

  • Jul 02, 2012
    After two days of deliberations in pain pump case, the judge ordered a mistrial.
  • June 3, 2019
    Bowman and Brooke continued a long tradition of high national ranking as The Legal 500 named the firm a top national practice in four product liability industries. Bowman and Brooke received recognition for the firm’s work in automotive defense, pharmaceutical and medical device defense, consumer defense and toxic tort defense. Toxic Tort defense is a new ranking for the firm in The Legal 500
  • January 7, 2019
    Performing trials to evaluate the safety and efficacy of medicines and devices for a particular indication and patient population requires the navigation of complex medical, scientific, regulatory and ethical principles — and such trials, of course, often continue after approval as well, supporting additional indications and evaluating ongoing safety questions.
  • November 16, 2018
    Speaking Engagement

    Kim Schmid, Firm Vice Chair and Executive Managing Partner, spoke at the 23rd Annual ACI Drug and Medical Device Litigation Conference in New York City later this month. Kim joins a panel to present "Practical Ways for Incorporating Diversity and Inclusion into Your Trial Team and Litigation Strategy." This is widely regarded as the go-to annual conference for all things pharmaceutical and medical device products liability. 

  • September 18, 2018

    Law360 recently published an article addressing a recent study suggesting that triclosan, a common antibacterial agent that has links to cancer in mice.

  • October 13, 2016

    The 3D printing boom in the last several years has sweeping implications for the future of pharmaceuticals and medical devices. With the enormous potential 3D printed products have in the life sciences, there are equally as many unknowns regarding risk and liability throughout the supply chain.

Integrated Services

In addition to providing stellar legal counsel, we integrate our provision of other key services with the work of our legal teams. The result? Highly effective and efficient client service.

The Legal 500